-
First Whole Exome Sequence of Small-Intestine Carcinoids
Share this:
Researchers at Mayo Clinic have completed the world’s first whole exome sequence of small intestine neuroendocrine tumors, also known to patients and physicians as carcinoids, the most common cancer of the small bowel and one that responds poorly to chemotherapy. Mayo oncologist and lead author Michaela Banck, M.D., says, “This is a very important step in achieving targeted therapies and individualized treatment approaches for patients with small bowel carcinoids. Genomic analysis of the individual patient’s tumors will help us identify new drugs that are targeted to the individual’s disease.”
Click here for news release
Sound bites with Dr. Banck are in the downloads
Expert title for broadcast cg: Michaela Banck, M.D., Mayo Clinic Oncologist
Share this:
Related articles
National Influenza Vaccination Week will be observed Dec. 4–8, which makes this a good time to learn more about the flu and why it's especially important ...
When David Elder’s back started to hurt in the fall of 2022, he thought his recurrent spasms had returned. But when medication didn’t help like ...
When Joanina Gicobi began her Ph.D. degree five years ago at Mayo Clinic Graduate School of Biomedical Sciences, she was interested in thinking creatively about ways ...